Understanding CD4+ T cells in autoimmune bullous diseases
Open accessThe DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Abstract
Autoimmune bullous diseases (AIBDs) are a group of life-threatening blistering diseases caused by autoantibodies that target proteins in the skin and mucosa. Autoantibodies are the most important mediator in the pathogenesis of AIBDs, and various immune mechanisms contribute to the production of these pathogenic autoantibodies. Recently, significant progress has been made in understanding how CD4+ T cells drive autoantibody production in these diseases. Here, we review the critical role of CD4+ T cells in the production of pathogenic autoantibodies for the initiation and perpetuation of humoral response in AIBDs. To gain an in-depth understanding of CD4+ T-cell pathogenicity, antigen specificity, and mechanisms of immune tolerance, this review covers comprehensive mouse and human studies of pemphigus and bullous pemphigoid. Further exploration of pathogenic CD4+ T cells will potentially provide immune targets for improved treatment of AIBDs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous studies in AIDs, including NMOSD, mainly identify T cells with pro-inflammatory or B cell helper function. 16,24-31”
From Autoantigen-specific CD4+ T cells acquire an exhausted phenotype and persist in human antigen-specific autoimmune diseases (2024) · cites this paper as [30]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Auto-Th cells with a pro-inflammatory or B cell helper profile are seen in AID patients, 16,24-31 but comprehensive ex vivo analyses are missing.”
From Autoantigen-specific CD4+ T cells acquire an exhausted phenotype and persist in human antigen-specific autoimmune diseases (2024) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulatory T Cells and Human Disease
Sakaguchi, S., Mikami, N., Wing, J. B., Tanaka, A., Ichiyama, K., & Ohkura, N. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042718-041717 · Cited by 1,120 · cited 1×
“Human CD25FoxP3 Tregs are subdivided into three populations based on CD45RA and FoxP3 expression; CD45RAFoxP naïve Treg, CD45RAFoxP3 effector Treg, and CD45RAFoxP3 non-suppressive T cells (76).”
BackgroundAutoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion
Amagai, M., Klaus-Kovtun, V., & Stanley, J. R. (1991) · Cell · doi:10.1016/0092-8674(91)90360-b · Cited by 1,021
A Comparison of Oral and Topical Corticosteroids in Patients with Bullous Pemphigoid
Joly, P., Roujeau, J.-C., Benichou, J., Picard, C., Dreno, B., Delaporte, E., Vaillant, L., D'Incan, M., Plantin, P., Bedane, C., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011592 · Cited by 626 · cited 1×
“First-line treatment options are topical and systemic corticosteroids (46, 47).”
BackgroundJoly, P., Maho-Vaillant, M., Prost-Squarcioni, C., Hebert, V., Houivet, E., Calbo, S., Caillot, F., Golinski, M. L., Labeille, B., Picard-Dahan, C., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30070-3 · Cited by 623
Kasperkiewicz, M., Ellebrecht, C. T., Takahashi, H., Yamagami, J., Zillikens, D., Payne, A. S., & Amagai, M. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.26 · Cited by 523
A Single Cycle of Rituximab for the Treatment of Severe Pemphigus
Joly, P., Mouquet, H., Roujeau, J.-C., D'Incan, M., Gilbert, D., Jacquot, S., Gougeon, M.-L., Bedane, C., Muller, R., Dreno, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067752 · Cited by 466
Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility
Xu, H., Li, X., Liu, D., Li, J., Zhang, X., Chen, X., Hou, S., Peng, L., Xu, C., Liu, W., et al. (2013) · Nature · doi:10.1038/nature12058 · Cited by 387 · cited 1×
“Tfh cells are the major cells that directly interact with B cells, and ICOS is an important co-stimulator that maintains the phenotype of Tfh cells and promotes the migration of Tfh cells to the germinal center (25, 26).”
BackgroundDiaz, L. A., Ratrie, H., Saunders, W. S., Futamura, S., Squiquera, H. L., Anhalt, G. J., & Giudice, G. J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114812 · Cited by 368 · cited 1×
“Bullous pemphigoid (BP) is an AIBD characterized by autoantibodies against bullous pemphigoid antigens (BPAG) 1 and 2, and is distinguished from pemphigus in that blisters develop in the subepidermal layer (41, 42).”
BackgroundBilgiç Temel, A., Bassorgun, C. I., Akman-Karakaş, A., Alpsoy, E., & Uzun, S. (2017) · Case Reports in Dermatology · doi:10.1159/000452828 · Cited by 363
Joly, P., Horvath, B., Patsatsi, Α., Uzun, S., Bech, R., Beissert, S., Bergman, R., Bernard, P., Borradori, L., Caproni, M., et al. (2020) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16752 · Cited by 363 · cited 1×
“In that reason, steroid-sparing agents such as mycophenolate mofetil and azathioprine are often combined (7).”
Background
Cited by
Saggau, C., Bacher, P., Esser, D., Rasa, M., Meise, S., Mohr, N., Kohlstedt, N., Hutloff, A., Schacht, S.-S., Dargvainiene, J., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.08.005 · Cited by 79
Microenvironmental network of clonal CXCL13+CD4+ T cells and Tregs in pemphigus chronic blisters
Han, D., Lee, A., Kim, T., Choi, J. Y., Cho, M. Y., Song, A., Kim, C.-H., Shim, J., Kim, H. J., Kim, H., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci166357 · Cited by 41
“The role of TLSs in the pathogenesis of pemphigus remains unknown, although TLSs have been detected in inflamed lesions in patients with pemphigus (17, 18).”
Self-citationLin, X., Li, X., Zhai, Z., & Zhang, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1563286 · Cited by 29
“This cytokine milieu fosters B cells differentiation and the production of IgG and IgE autoantibodies (236).”
Mima, Y., Ohtsuka, T., Ebato, I., Nakazato, Y., & Norimatsu, Y. (2024) · Diagnostics · doi:10.3390/diagnostics14171958 · Cited by 6
“CD4 + T cells, particularly Th2 cells, play a significant role in BP by interacting with B cells through CD40-CD40L interactions, leading to B cell differentiation and epitope spreading of IgG and IgE autoantibodies [41].”
BackgroundTavakolpour, S., Nili, A., Munaretto, L., Huang, C. K., Rakhshandehroo, T., Kim, Z., Knight, A. E., Farid, A. S., Alasharee, M., Allen, H. H., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adk6484 · Cited by 6
Metadata
- Authors
- Lee, A. Y., Kim, T., & Kim, J. H.
- Affiliations
- Yonsei University (KR)
- Corresponding author
- Kim, Jong Hoon
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2023-04-17
- Volume
- 14
- Pages
- 1161927-1161927
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC10149917
- OpenAlex
- W4366227066
- Cited by
- 13
- References
- 79
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 4 · 2023: 1
- FWCI
- 0.59
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Korea Drug Development Fund (RS-2022-00165917)
- Topics
- Health Sciences › Medicine › Dermatology › Autoimmune Bullous Skin Diseases
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Skin and Cellular Biology Research
- Keywords
- autoimmune blistering disease, CD4+ T cells, autoantibodies, pemphigus, bullous pemphigoid, humoral immune response, immune tolerance, antigen specificity, blistering skin disease
- MeSH terms
- Animals, Autoantibodies, Autoimmune Diseases, Humans, Skin Diseases, Vesiculobullous, T-Lymphocytes, CD4-Positive T-Lymphocytes, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Understanding CD4+ T cells in autoimmune bullous diseases. https://app.cochat.ai/papers/10.3389/fimmu.2023.1161927
- The paper
- Lee, A. Y., Kim, T., & Kim, J. H. (2023). Understanding CD4+ T cells in autoimmune bullous diseases. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2023.1161927
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.